Recital 31, Directive (EU) 2011/24

In forcesince 9 Mar 2011cited 2×

Patients should not be deprived of the more beneficial rights guaranteed by the Union Regulations on the coordination of social security systems when the conditions are met. Therefore, any patient who requests an authorisation to receive treatment appropriate to his condition in another Member State should always be granted this authorisation under the conditions provided for in the Unions regulations when the treatment in question is among the benefits provided for by the legislation in the Member State where the patient resides and when the patient cannot be given such treatment within a time limit that is medically justifiable, taking account of his current state of health and the probable course of the condition. However, if a patient instead explicitly requests to seek treatment under the terms of this Directive, the benefits which apply to reimbursement should be limited to those which apply under this Directive. Where the patient is entitled to cross-border healthcare under both this Directive and Regulation (EC) No 883/2004, and the application of that Regulation is more advantageous to the patient, the patient’s attention should be drawn to this by the Member State of affiliation.

  • Judgment of the Court (Fourth Chamber) of 4 September 2025. AF v Guvernul României and Others.Decision

    Accordingly, the question of the applicability, to a factual situation, of Regulation No 883/2004 or of Directive 2011/24 depends on the choice of the insured person and the duty of the Member State of affiliation to advise the patient …

    4 Sep 2025 · 62023CJ0489

  • Opinion of Advocate General Hogan delivered on 30 April 2020. A v Veselības ministrija.Decision

    What is at issue in the present case is the issuance of what is known as the S2 form to B in order that he may benefit from cross-border healthcare in another Member State. The issuance of that form would appear to be based, inter alia, on …

    30 Apr 2020 · 62019CC0243